These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 12110950

  • 21. High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules.
    Zeng J, Fournier P, Schirrmacher V.
    Int J Oncol; 2004 Aug; 25(2):293-302. PubMed ID: 15254725
    [Abstract] [Full Text] [Related]

  • 22. Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus.
    Bian H, Fournier P, Moormann R, Peeters B, Schirrmacher V.
    Cancer Gene Ther; 2005 Mar; 12(3):295-303. PubMed ID: 15605075
    [Abstract] [Full Text] [Related]

  • 23. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus.
    McGinnes LW, Morrison TG.
    Virology; 1994 May 01; 200(2):470-83. PubMed ID: 8178436
    [Abstract] [Full Text] [Related]

  • 24. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.
    Sergel T, McGinnes LW, Peeples ME, Morrison TG.
    Virology; 1993 Apr 01; 193(2):717-26. PubMed ID: 8384752
    [Abstract] [Full Text] [Related]

  • 25. A single amino acid substitution in the haemagglutinin-neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotype.
    Estevez C, King DJ, Luo M, Yu Q.
    J Gen Virol; 2011 Mar 01; 92(Pt 3):544-51. PubMed ID: 21123551
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation.
    Payvandi F, Amrute S, Fitzgerald-Bocarsly P.
    J Immunol; 1998 Jun 15; 160(12):5861-8. PubMed ID: 9637497
    [Abstract] [Full Text] [Related]

  • 29. Interferon-induction in mouse spleen cells by the Newcastle disease virus (NDV) HN protein.
    Jestin V, Cherbonnel M.
    Ann Rech Vet; 1991 Jun 15; 22(4):365-72. PubMed ID: 1725587
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Paramyxovirus fusion (F) protein and hemagglutinin-neuraminidase (HN) protein interactions: intracellular retention of F and HN does not affect transport of the homotypic HN or F protein.
    Paterson RG, Johnson ML, Lamb RA.
    Virology; 1997 Oct 13; 237(1):1-9. PubMed ID: 9344902
    [Abstract] [Full Text] [Related]

  • 32. Overexpression of Newcastle disease virus (NDV) V protein enhances NDV production kinetics in chicken embryo fibroblasts.
    Jang J, Hong SH, Choi D, Choi KS, Kang S, Kim IH.
    Appl Microbiol Biotechnol; 2010 Feb 13; 85(5):1509-20. PubMed ID: 19730851
    [Abstract] [Full Text] [Related]

  • 33. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein.
    Bian H, Fournier P, Moormann R, Peeters B, Schirrmacher V.
    Int J Oncol; 2005 Feb 13; 26(2):431-9. PubMed ID: 15645128
    [Abstract] [Full Text] [Related]

  • 34. Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.
    Schirrmacher V, Haas C, Bonifer R, Ertel C.
    Clin Cancer Res; 1997 Jul 13; 3(7):1135-48. PubMed ID: 9815793
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Suppression of innate immune cytokines and interferon regulatory factor-1 by endogenous interferon-alpha in response to respiratory syncytial virus in neonate mononuclear cells.
    Krishnan S, Halonen M.
    Immunol Invest; 2007 Jul 13; 36(4):441-56. PubMed ID: 17691025
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.